Jane Street’s Revolution Medicines RVMD Stock Holding History

Jane Street’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.2M	Buy	197,900 +154,400	+355%	+$15.6M	﹤0.01%	1809
2025 Q4	$3.46M	Sell	43,500 -387,800	-90%	-$25.4M	﹤0.01%	3811
2025 Q3	$20.1M	Buy	431,300 +53,500	+14%	+$2.09M	﹤0.01%	1654
2025 Q2	$13.9M	Buy	377,800 +2,000	+0.5%	+$76.8K	﹤0.01%	1790
2025 Q1	$13.3M	Sell	375,800 -57,600	-13%	-$2.34M	﹤0.01%	1668
2024 Q4	$19M	Buy	433,400 +176,500	+69%	+$8.91M	﹤0.01%	1299
2024 Q3	$11.7M	Buy	256,900 +238,000	+1,259%	+$10.4M	﹤0.01%	1765
2024 Q2	$734K	Buy	+18,900	New	+$706K	﹤0.01%	6360

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jane Street's RVMD Position: Q1 2026 in Review

Jane Street reduced its Revolution Medicines (RVMD) stake by 97% in Q1 2026, selling an estimated $107M and leaving 33,603 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #4189.

Jane Street first reported a position in RVMD in Q1 2021 and has held it in 18 quarters since. The position peaked at $86.9M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Jane Street held 33,603 shares of Revolution Medicines worth $3.27M as of Q1 2026.
Jane Street sold 1,056,813 Revolution Medicines shares in Q1 2026, an estimated $107M.
Revolution Medicines made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4189 holding.
Jane Street first reported a position in Revolution Medicines in Q1 2021 and has held it in 18 quarters since.
Jane Street's Revolution Medicines position peaked at $86.9M in Q4 2025.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.